The global hypertensive heart diseases market is anticipated to grow at a CAGR of around 3.5% during the forecast period (2024-2031). The prevalence of hypertensive heart disease in North America is the major factor driving the growth of the region. The growing aging population in the US accelerating the demand for hypertensive heart disease treatments and drugs. As per the Urban Institutes, the aging population over 65 in America is expected to be double over the next 40 years, reaching 80 million in 2040. Hypertension is the major cause of heart disease in the US population. In 2018, nearly half a million deaths in the US included hypertension as a primary or contributing cause as per the CDC estimates. According to the CDC, hypertension in the US costs around $48.6 billion every year. This cost includes the cost related to the medication, healthcare services, and other related healthcare services.
Get Free Sample link @ https://www.omrglobal.com/request-sample/hypertensive-heart-disease-market
The rising healthcare expenditure, and government grants, and rising awareness about hypertension are also the factors accelerating the growth of the market. The US spending on healthcare is more than any other country. The federal government is the major source of US healthcare spending. According to the Tax Policy Center, in 2019, around $1.2 trillion on healthcare was spend by the US federal government. Whereas, as per the Canadian Institute for Health Information, in 2019, Canada spent nearly $265.5 billion as healthcare expenditure. Which was 11.5% of Canada’s gross domestic product (GDP). Moreover, regional growth is also impacted by the presence of major players. The various strategies such as mergers and acquisition, new product launch, and expenditure on R&D adopted by the major players has accelerated the growth of the market.
Full report of Hypertensive Heart Diseases Market available @ https://www.omrglobal.com/industry-reports/hypertensive-heart-disease-market
Market Coverage
- Segment Covered-
o By Diagnosis
o By Therapeutic
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- Abbott Laboratories, AstraZeneca PLC, Bayer AG, Boehringer Ingelheim International GmbH, Johnson & Johnson Services Inc., Merck KGaA, Novartis AG, Pfizer Inc., and Sanofi SA, among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Hypertensive Heart Diseases Market Report Segment
By Diagnosis
- Electrocardiogram
- Echocardiogram
- Coronary Angiography
- Others (Chest X-Ray)
By Therapeutics
- Drugs
o Thiazide Diuretics
o Beta-Blockers
o Angiotensin-Converting Enzyme (ACE) Inhibitors
o Angiotensin II Receptor Blockers (ARB)
o Calcium Channel Blockers
o Others (Renin Inhibitors)
- Surgery
o Coronary Artery Bypass Surgery
o Transmyocardial Laser Revascularization
o Heart Transplant
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/hypertensive-heart-disease-market
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
